List of Chapters/Sections(Table Of Content)
1 Introduction to Research & Analysis Reports
1.1 Spinal Muscular Atrophy Medicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Spinal Muscular Atrophy Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Spinal Muscular Atrophy Medicine Overall Market Size
2.1 Global Spinal Muscular Atrophy Medicine Market Size: 2021 VS 2028
2.2 Global Spinal Muscular Atrophy Medicine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Spinal Muscular Atrophy Medicine Sales: 2017-2028
3 Company Landscape
3.1 Top Spinal Muscular Atrophy Medicine Players in Global Market
3.2 Top Global Spinal Muscular Atrophy Medicine Companies Ranked by Revenue
3.3 Global Spinal Muscular Atrophy Medicine Revenue by Companies
3.4 Global Spinal Muscular Atrophy Medicine Sales by Companies
3.5 Global Spinal Muscular Atrophy Medicine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Spinal Muscular Atrophy Medicine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Spinal Muscular Atrophy Medicine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Spinal Muscular Atrophy Medicine Players in Global Market
3.8.1 List of Global Tier 1 Spinal Muscular Atrophy Medicine Companies
3.8.2 List of Global Tier 2 and Tier 3 Spinal Muscular Atrophy Medicine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Spinal Muscular Atrophy Medicine Market Size Markets, 2021 & 2028
4.1.2 LMI-070
4.1.3 ND-602
4.1.4 NT-1654
4.1.5 Nusinersen
4.1.6 NXD-30001
4.1.7 Others
4.2 By Type - Global Spinal Muscular Atrophy Medicine Revenue & Forecasts
4.2.1 By Type - Global Spinal Muscular Atrophy Medicine Revenue, 2017-2022
4.2.2 By Type - Global Spinal Muscular Atrophy Medicine Revenue, 2023-2028
4.2.3 By Type - Global Spinal Muscular Atrophy Medicine Revenue Market Share, 2017-2028
4.3 By Type - Global Spinal Muscular Atrophy Medicine Sales & Forecasts
4.3.1 By Type - Global Spinal Muscular Atrophy Medicine Sales, 2017-2022
4.3.2 By Type - Global Spinal Muscular Atrophy Medicine Sales, 2023-2028
4.3.3 By Type - Global Spinal Muscular Atrophy Medicine Sales Market Share, 2017-2028
4.4 By Type - Global Spinal Muscular Atrophy Medicine Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Spinal Muscular Atrophy Medicine Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Spinal Muscular Atrophy Medicine Revenue & Forecasts
5.2.1 By Application - Global Spinal Muscular Atrophy Medicine Revenue, 2017-2022
5.2.2 By Application - Global Spinal Muscular Atrophy Medicine Revenue, 2023-2028
5.2.3 By Application - Global Spinal Muscular Atrophy Medicine Revenue Market Share, 2017-2028
5.3 By Application - Global Spinal Muscular Atrophy Medicine Sales & Forecasts
5.3.1 By Application - Global Spinal Muscular Atrophy Medicine Sales, 2017-2022
5.3.2 By Application - Global Spinal Muscular Atrophy Medicine Sales, 2023-2028
5.3.3 By Application - Global Spinal Muscular Atrophy Medicine Sales Market Share, 2017-2028
5.4 By Application - Global Spinal Muscular Atrophy Medicine Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Spinal Muscular Atrophy Medicine Market Size, 2021 & 2028
6.2 By Region - Global Spinal Muscular Atrophy Medicine Revenue & Forecasts
6.2.1 By Region - Global Spinal Muscular Atrophy Medicine Revenue, 2017-2022
6.2.2 By Region - Global Spinal Muscular Atrophy Medicine Revenue, 2023-2028
6.2.3 By Region - Global Spinal Muscular Atrophy Medicine Revenue Market Share, 2017-2028
6.3 By Region - Global Spinal Muscular Atrophy Medicine Sales & Forecasts
6.3.1 By Region - Global Spinal Muscular Atrophy Medicine Sales, 2017-2022
6.3.2 By Region - Global Spinal Muscular Atrophy Medicine Sales, 2023-2028
6.3.3 By Region - Global Spinal Muscular Atrophy Medicine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Spinal Muscular Atrophy Medicine Revenue, 2017-2028
6.4.2 By Country - North America Spinal Muscular Atrophy Medicine Sales, 2017-2028
6.4.3 US Spinal Muscular Atrophy Medicine Market Size, 2017-2028
6.4.4 Canada Spinal Muscular Atrophy Medicine Market Size, 2017-2028
6.4.5 Mexico Spinal Muscular Atrophy Medicine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Spinal Muscular Atrophy Medicine Revenue, 2017-2028
6.5.2 By Country - Europe Spinal Muscular Atrophy Medicine Sales, 2017-2028
6.5.3 Germany Spinal Muscular Atrophy Medicine Market Size, 2017-2028
6.5.4 France Spinal Muscular Atrophy Medicine Market Size, 2017-2028
6.5.5 U.K. Spinal Muscular Atrophy Medicine Market Size, 2017-2028
6.5.6 Italy Spinal Muscular Atrophy Medicine Market Size, 2017-2028
6.5.7 Russia Spinal Muscular Atrophy Medicine Market Size, 2017-2028
6.5.8 Nordic Countries Spinal Muscular Atrophy Medicine Market Size, 2017-2028
6.5.9 Benelux Spinal Muscular Atrophy Medicine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Spinal Muscular Atrophy Medicine Revenue, 2017-2028
6.6.2 By Region - Asia Spinal Muscular Atrophy Medicine Sales, 2017-2028
6.6.3 China Spinal Muscular Atrophy Medicine Market Size, 2017-2028
6.6.4 Japan Spinal Muscular Atrophy Medicine Market Size, 2017-2028
6.6.5 South Korea Spinal Muscular Atrophy Medicine Market Size, 2017-2028
6.6.6 Southeast Asia Spinal Muscular Atrophy Medicine Market Size, 2017-2028
6.6.7 India Spinal Muscular Atrophy Medicine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Spinal Muscular Atrophy Medicine Revenue, 2017-2028
6.7.2 By Country - South America Spinal Muscular Atrophy Medicine Sales, 2017-2028
6.7.3 Brazil Spinal Muscular Atrophy Medicine Market Size, 2017-2028
6.7.4 Argentina Spinal Muscular Atrophy Medicine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Spinal Muscular Atrophy Medicine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Spinal Muscular Atrophy Medicine Sales, 2017-2028
6.8.3 Turkey Spinal Muscular Atrophy Medicine Market Size, 2017-2028
6.8.4 Israel Spinal Muscular Atrophy Medicine Market Size, 2017-2028
6.8.5 Saudi Arabia Spinal Muscular Atrophy Medicine Market Size, 2017-2028
6.8.6 UAE Spinal Muscular Atrophy Medicine Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Astellas Pharma Inc.
7.1.1 Astellas Pharma Inc. Corporate Summary
7.1.2 Astellas Pharma Inc. Business Overview
7.1.3 Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Major Product Offerings
7.1.4 Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Sales and Revenue in Global (2017-2022)
7.1.5 Astellas Pharma Inc. Key News
7.2 AveXis, Inc.
7.2.1 AveXis, Inc. Corporate Summary
7.2.2 AveXis, Inc. Business Overview
7.2.3 AveXis, Inc. Spinal Muscular Atrophy Medicine Major Product Offerings
7.2.4 AveXis, Inc. Spinal Muscular Atrophy Medicine Sales and Revenue in Global (2017-2022)
7.2.5 AveXis, Inc. Key News
7.3 Bioblast Pharma Ltd.
7.3.1 Bioblast Pharma Ltd. Corporate Summary
7.3.2 Bioblast Pharma Ltd. Business Overview
7.3.3 Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Major Product Offerings
7.3.4 Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Sales and Revenue in Global (2017-2022)
7.3.5 Bioblast Pharma Ltd. Key News
7.4 Cytokinetics, Inc. 24
7.4.1 Cytokinetics, Inc. 24 Corporate Summary
7.4.2 Cytokinetics, Inc. 24 Business Overview
7.4.3 Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Major Product Offerings
7.4.4 Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Sales and Revenue in Global (2017-2022)
7.4.5 Cytokinetics, Inc. 24 Key News
7.5 F. Hoffmann-La Roche Ltd.
7.5.1 F. Hoffmann-La Roche Ltd. Corporate Summary
7.5.2 F. Hoffmann-La Roche Ltd. Business Overview
7.5.3 F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Major Product Offerings
7.5.4 F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Sales and Revenue in Global (2017-2022)
7.5.5 F. Hoffmann-La Roche Ltd. Key News
7.6 Genethon
7.6.1 Genethon Corporate Summary
7.6.2 Genethon Business Overview
7.6.3 Genethon Spinal Muscular Atrophy Medicine Major Product Offerings
7.6.4 Genethon Spinal Muscular Atrophy Medicine Sales and Revenue in Global (2017-2022)
7.6.5 Genethon Key News
7.7 Genzyme Corporation
7.7.1 Genzyme Corporation Corporate Summary
7.7.2 Genzyme Corporation Business Overview
7.7.3 Genzyme Corporation Spinal Muscular Atrophy Medicine Major Product Offerings
7.7.4 Genzyme Corporation Spinal Muscular Atrophy Medicine Sales and Revenue in Global (2017-2022)
7.7.5 Genzyme Corporation Key News
7.8 GMP-Orphan SAS
7.8.1 GMP-Orphan SAS Corporate Summary
7.8.2 GMP-Orphan SAS Business Overview
7.8.3 GMP-Orphan SAS Spinal Muscular Atrophy Medicine Major Product Offerings
7.8.4 GMP-Orphan SAS Spinal Muscular Atrophy Medicine Sales and Revenue in Global (2017-2022)
7.8.5 GMP-Orphan SAS Key News
7.9 Ionis Pharmaceuticals, Inc.
7.9.1 Ionis Pharmaceuticals, Inc. Corporate Summary
7.9.2 Ionis Pharmaceuticals, Inc. Business Overview
7.9.3 Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Major Product Offerings
7.9.4 Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Sales and Revenue in Global (2017-2022)
7.9.5 Ionis Pharmaceuticals, Inc. Key News
7.10 Longevity Biotech, Inc
7.10.1 Longevity Biotech, Inc Corporate Summary
7.10.2 Longevity Biotech, Inc Business Overview
7.10.3 Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Major Product Offerings
7.10.4 Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Sales and Revenue in Global (2017-2022)
7.10.5 Longevity Biotech, Inc Key News
7.11 Neurodyn Inc.
7.11.1 Neurodyn Inc. Corporate Summary
7.11.2 Neurodyn Inc. Spinal Muscular Atrophy Medicine Business Overview
7.11.3 Neurodyn Inc. Spinal Muscular Atrophy Medicine Major Product Offerings
7.11.4 Neurodyn Inc. Spinal Muscular Atrophy Medicine Sales and Revenue in Global (2017-2022)
7.11.5 Neurodyn Inc. Key News
7.12 Neurotune AG
7.12.1 Neurotune AG Corporate Summary
7.12.2 Neurotune AG Spinal Muscular Atrophy Medicine Business Overview
7.12.3 Neurotune AG Spinal Muscular Atrophy Medicine Major Product Offerings
7.12.4 Neurotune AG Spinal Muscular Atrophy Medicine Sales and Revenue in Global (2017-2022)
7.12.5 Neurotune AG Key News
7.13 Novartis AG
7.13.1 Novartis AG Corporate Summary
7.13.2 Novartis AG Spinal Muscular Atrophy Medicine Business Overview
7.13.3 Novartis AG Spinal Muscular Atrophy Medicine Major Product Offerings
7.13.4 Novartis AG Spinal Muscular Atrophy Medicine Sales and Revenue in Global (2017-2022)
7.13.5 Novartis AG Key News
7.14 Sarepta Therapeutics, Inc.
7.14.1 Sarepta Therapeutics, Inc. Corporate Summary
7.14.2 Sarepta Therapeutics, Inc. Business Overview
7.14.3 Sarepta Therapeutics, Inc. Spinal Muscular Atrophy Medicine Major Product Offerings
7.14.4 Sarepta Therapeutics, Inc. Spinal Muscular Atrophy Medicine Sales and Revenue in Global (2017-2022)
7.14.5 Sarepta Therapeutics, Inc. Key News
7.15 Voyager Therapeutics, Inc.
7.15.1 Voyager Therapeutics, Inc. Corporate Summary
7.15.2 Voyager Therapeutics, Inc. Business Overview
7.15.3 Voyager Therapeutics, Inc. Spinal Muscular Atrophy Medicine Major Product Offerings
7.15.4 Voyager Therapeutics, Inc. Spinal Muscular Atrophy Medicine Sales and Revenue in Global (2017-2022)
7.15.5 Voyager Therapeutics, Inc. Key News
7.16 Vybion, Inc.
7.16.1 Vybion, Inc. Corporate Summary
7.16.2 Vybion, Inc. Business Overview
7.16.3 Vybion, Inc. Spinal Muscular Atrophy Medicine Major Product Offerings
7.16.4 Vybion, Inc. Spinal Muscular Atrophy Medicine Sales and Revenue in Global (2017-2022)
7.16.5 Vybion, Inc. Key News
7.17 WAVE Life Sciences Ltd.
7.17.1 WAVE Life Sciences Ltd. Corporate Summary
7.17.2 WAVE Life Sciences Ltd. Business Overview
7.17.3 WAVE Life Sciences Ltd. Spinal Muscular Atrophy Medicine Major Product Offerings
7.17.4 WAVE Life Sciences Ltd. Spinal Muscular Atrophy Medicine Sales and Revenue in Global (2017-2022)
7.17.5 WAVE Life Sciences Ltd. Key News
8 Global Spinal Muscular Atrophy Medicine Production Capacity, Analysis
8.1 Global Spinal Muscular Atrophy Medicine Production Capacity, 2017-2028
8.2 Spinal Muscular Atrophy Medicine Production Capacity of Key Manufacturers in Global Market
8.3 Global Spinal Muscular Atrophy Medicine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Spinal Muscular Atrophy Medicine Supply Chain Analysis
10.1 Spinal Muscular Atrophy Medicine Industry Value Chain
10.2 Spinal Muscular Atrophy Medicine Upstream Market
10.3 Spinal Muscular Atrophy Medicine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Spinal Muscular Atrophy Medicine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
